🇺🇸 FDA
Patent

US 10231955

Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery

granted A61KA61K31/436A61K38/13

Quick answer

US patent 10231955 (Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery) held by The Board of Regents of the University of Texas System expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/436, A61K38/13, A61K9/0075, A61K9/0078